Annual Report 2024

2025, Volume 9, Issue 1: 1-7. doi: 10.3934/Allergy.2025001

Previous Article Next Article

Editorial

1.
Department of Innovative Technologies in Medicine and Dentistry, Unit of Immunity and Molecular Pathology, School of Medicine and Health Sciences, University “G. d'Annunzio” Chieti-Pescara, Via dei Vestini, 66100 Chieti, Italy
2.
AIMS Press, Springfield, MO 65801-2604, USA

Received: 21 February 2025 Revised: 21 February 2025 Accepted: 21 February 2025 Published: 21 February 2025

This editorial note is dedicated to the 2024 Journal report of AIMS Allergy and Immunology, which was run by AIMS Press. After a brief summary about the annual development in 2024, future developments of the journal in 2025 are proposed. The impact factor for AIMS Allergy and Immunology increased from 0.7 to 0.9.

Citation: Marcella Reale, Xu Guo. Annual Report 2024[J]. AIMS Allergy and Immunology, 2025, 9(1): 1-7. doi: 10.3934/Allergy.2025001

Related Papers:
Abstract

This editorial note is dedicated to the 2024 Journal report of AIMS Allergy and Immunology, which was run by AIMS Press. After a brief summary about the annual development in 2024, future developments of the journal in 2025 are proposed. The impact factor for AIMS Allergy and Immunology increased from 0.7 to 0.9.

Acknowledgments

We very much appreciate the time and effort of all our editorial board members and guest editors, as well as our reviewers. All of these excellent experts provided us with very useful and professional suggestions in 2024. Many thanks to you all. Last, but not least, thanks are given to the hard work of the in-house editorial team.
Reader Comments

Your name:*

Email:*
© 2025 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)